Chapter 2
References
- Access to antiretroviral treatment and care: the experience of the HIV Equity Initiative, Cange, Haiti. Geneva, World Health Organization, 2003 (http://www.who.int/hiv/pub/ prev_care/en/Haiti_E_Final2004.pdf, accessed 16 February 2004).
- Antiretroviral therapy in primary health care: experience of the Khayelitsha programme in South Africa. Geneva, World Health Organization, 2003 (2. http://www.who.int/hiv/pub/ prev_care/en/South_Africa_E.pdf, accessed 16 February 2004).
- Scaling up antiretroviral therapy: experience in Uganda. Geneva, World Health Organization, 2003 (Perspectives and Practice in Antiretroviral Treatment Series; http://www.who. int/hiv/pub/prev_care/en/Uganda_E.pdf, accessed 16 February 2004).
- Farmer P, Léandre F, Mukherjee JS, Gupta R, Tarter L, Yong Kim J. Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy). Bulletin of the World Health Organization, 2001, 79:1145–1151.
- Centers for Disease Control and Prevention. Advancing HIV prevention: new strategies for a changing epidemic – United States. Morbidity and Mortality Weekly Report, 2003, 52:329–332.
- The long-run economic costs of AIDS: theory and application to South Africa. Washington, DC, World Bank, 2003.
- The world health report 2002 – Reducing risks, promoting healthy life. Geneva, World Health Organization, 2002.
- Teixeira PR, Antônio Vitória M, Barcarolo J. The Brazilian experience in providing universal access to antiretroviral therapy (http://www.iaen.org/fi les.cgi/11066_part_1_n2_Teixeira. pdf, accessed 16 February 2004).
- Marins JR, Jamal LF, Chen SY, Barros MB, Hudes ES, Barbosa AA et al. Dramatic improvement in survival among Brazilian AIDS patients. AIDS, 2003, 17:1675–1682.
- WHO/UNAIDS. Treating 3 million by 2005: making it happen. The WHO strategy. Geneva, World Health Organization, 2003.
- Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach. 2003 revision. Geneva, World Health Organization, 2003 (http:// www.who.int/3by5/publications/en/ARVGuidelinesRevised2003.pdf, accessed 16 February 2004).
- Badri M, Wood R. Usefulness of total lymphocyte count in monitoring highly active antiretroviral therapy in resource-limited settings. AIDS, 2003, 17:541–545.
- Kumarasamy N, Mahajan AP, Flanigan TP, Hemalatha R, Mayer KH, Carpenter CC et al. Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries. Journal of Acquired Immune Defi ciency Syndromes, 2002, 31:378–383.
- van der Ryst E, Kotze M, Joubert G, Steyn M, Pieters H, van der Westhuizen M et al. Correlation among total lymphocyte count, absolute CD4+ count, and CD4+ percentage in a group of HIV-1-infected South African patients. Journal of Acquired Immune Defi ciency Syndromes, 1998, 19:238–244.
- Stevens W, Kaye S, Corrah T. Antiretroviral therapy in Africa. BMJ, 2004, 328:280–282.
- How will the 3 by 5 initiative deal with HIV drugs resistance? Geneva, World Health Organization, 2003 (WHO/HIV/2003.10; http://www.who.int/3by5/publications/briefs/en/ drug_resistance.pdf, accessed 17 February 2004).
- Guidelines for surveillance of HIV drug resistance. Geneva, World Health Organization (draft document for review; http://www.who.int/3by5/publications/documents/ hivdrugsurveillance/en/, accessed 16 February 2004).
- WHO/UNAIDS. Estimated cost to reach the target of 3 million with access to antiretroviral therapy by 2005 (“3 by 5”). Geneva, World Health Organization (http://www.who.int/3by5/ publications/documents/en/cost_of_3by5.pdf, accessed 17 February 2004).
- Chaudhury R, Bapna S. Effect of interventions on rational use of drugs. Paper presented at: Conference on the State of the Art and Future Directions, Chiang Mai, Thailand, 1–4 April 1997 (http://www.who.int/dap-icium/posters/4D1_TEXT.html, accessed 17 February 2004).
- Zambia poverty reduction strategy paper 2002–2004. Lusaka, Ministry of Finance and National Planning, 2002.
- Brindeiro RM, Diaz RS, Sabino EC, Morgado MG, Pires IL, Brigido L et al. Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals. AIDS, 2003, 17:1063–1069.
- Szwarcwald CL, Bastos FI, Barcellos C, Esteves MAP, de Castilho EA. Dinâmica da epidemia de AIDS no Município do Rio de Janeiro, no período de 1988–1996: uma aplicação de análise estatística espaço-temporal [Spatial-temporal modelling: dynamics of the AIDS epidemic in the municipality of Rio de Janeiro, Brazil, 1988–1996]. Cadernos de Saúde Pública, 2001, 17:1123–1140.
- Marins JR, Jamal LF, Chen SY, Barros MB, Hudes ES, Barbosa AA. Dramatic improvement in survival among adult Brazilian AIDS patients. AIDS, 2003, 17:1675–1682.